The COVID-19 pandemic isn’t likely to end soon. Instead, the crisis stage may continue for weeks or even months before business regains some semblance of normality. The good news is that while biotech companies have slowed their hiring initiatives, layoffs remain unlikely at this point. Instead, biotech companies are enhancing flexibility on nearly every front.
Within this BioSpace Insight Report, Accomodating for the Novel Coronavirus, we take a look at how the pandemic is affecting the life sciences industry and the workplace.
